Literature DB >> 7657028

Elevated levels of authentic plasma hydroperoxides in NIDDM.

J Nourooz-Zadeh1, J Tajaddini-Sarmadi, S McCarthy, D J Betteridge, S P Wolff.   

Abstract

Using a precise technique for measuring authentic plasma lipid hydroperoxides (ROOHs), we show that individuals with non-insulin-dependent diabetes mellitus (NIDDM) have higher levels of ROOH than do control subjects. ROOHs were measured by the ferrous oxidation with xylenol orange assay coupled with the selective ROOH reductant triphenylphosphine. Formation of the ferric xylenol orange complex was determined at 560 nm and calibrated against H2O2. For 22 individuals with NIDDM, a concentration of 9.04 +/- 4.3 mumol/l (mean +/- SD) ROOH was recorded. This concentration was higher (P < 0.0005 by separate-variance t test) than that of plasma ROOHs from control subjects (3.76 +/- 2.48 mumol/l). There was no difference between concentrations of plasma malondialdehyde measured as thiobarbituric acid-reactive material (TBARM) in NIDDM or control subjects (1.00 +/- 0.70 vs. 1.21 +/- 0.62 mumol/l, respectively; P > 0.1). A trend to lower vitamin E levels in the NIDDM group (9.03 +/- 3.31 vs. 10.31 +/- 5.02 micrograms/ml in control subjects) failed to achieve significance at the 95% confidence level. Plasma ROOHs in the diabetic group did not correlate with total plasma cholesterol, triglyceride, fasting glucose, HbA1, vitamin E, or TBARM levels. These data indicate that measurement of authentic ROOHs shows NIDDM to be associated with oxidative stress, which may be unrelated to abnormalities in lipid metabolism and glycemic control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657028     DOI: 10.2337/diab.44.9.1054

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  50 in total

Review 1.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

3.  Parameters of oxidative stress status in healthy subjects: their correlations and stability after sample collection.

Authors:  Omidreza Firuzi; Premysl Mladenka; Valeria Riccieri; Antonio Spadaro; Rita Petrucci; Giancarlo Marrosu; Luciano Saso
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 4.  Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol?

Authors:  P Rösen; X Du; D Tschöpe
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

5.  Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

6.  Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study.

Authors:  Omer T Njajou; Alka M Kanaya; Paul Holvoet; Stephanie Connelly; Elsa S Strotmeyer; Tamara B Harris; Steve R Cummings; Wen-Chi Hsueh
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

7.  Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications.

Authors:  V Kolagal; S A Karanam; P K Dharmavarapu; R D'Souza; S Upadhya; V Kumar; V Kedage; M S Muttigi; J K Shetty; M Prakash
Journal:  Indian J Nephrol       Date:  2009-01

8.  Serum paraoxonase activity and protein thiols in chronic renal failure patients.

Authors:  M Prakash; J K Shetty; L Rao; S Sharma; A Rodrigues; R Prabhu
Journal:  Indian J Nephrol       Date:  2008-01

9.  Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset.

Authors:  Octavian Savu; Ovidiu Marius Bradescu; Cristian Serafinceanu; Liviu Iosif; Constantin Ionescu Tirgoviste; Irina Stoian
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

10.  Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.

Authors:  Michael F Hill
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.